Cargando…
An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
BACKGROUND: When a medicine such as rofecoxib (Vioxx) is withdrawn, or a whole class of medicines discredited such as the selective COX-2 inhibitors (COX-2s), follow-up of impacts at consumer level can be difficult and costly. The Australian Longitudinal Study on Women's Health provides a rare...
Autores principales: | Parkinson, Lynne, Doljagore, Xenia, Gibson, Richard, Doran, Evan, Notley, Lisa, Stewart Williams, Jenny, Kowal, Paul, Byles, Julie E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280381/ https://www.ncbi.nlm.nih.gov/pubmed/22114865 http://dx.doi.org/10.1186/1471-2458-11-892 |
Ejemplares similares
-
Market Withdrawal of Vioxx: Is it Time to Retihink the Use of COX-2 Inhibitors?
por: Ortiz, Eduardo
Publicado: (2004) -
Discreditable
Publicado: (1869) -
Merck's Actions Surrounding Vioxx
por: Heinley, Michael
Publicado: (2006) -
The discrediting of the monoamine hypothesis
por: Hinz, Marty, et al.
Publicado: (2012) -
The One Discredited Material
Publicado: (1894)